|
Volumn 11, Issue 2, 2014, Pages 412-418
|
Effects of Marketed Antiepileptic Drugs and Placebo in the Human Photosensitivity Screening Protocol
|
Author keywords
antiepileptic drug; carbamazepine; clinical trial; levetiracetam; Photosensitive epilepsy
|
Indexed keywords
CARBAMAZEPINE;
ETIRACETAM;
PLACEBO;
ANTICONVULSIVE AGENT;
PIRACETAM;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
EYELID CLOSURE;
FEMALE;
HUMAN;
MALE;
PHOTOSENSITIVITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
TREATMENT OUTCOME;
ANALOGS AND DERIVATIVES;
EPILEPSY, REFLEX;
LIGHT;
PLACEBO EFFECT;
ANTICONVULSANTS;
CARBAMAZEPINE;
DOUBLE-BLIND METHOD;
EPILEPSY, REFLEX;
FEMALE;
HUMANS;
LIGHT;
MALE;
PIRACETAM;
PLACEBO EFFECT;
|
EID: 84899141275
PISSN: 19337213
EISSN: 18787479
Source Type: Journal
DOI: 10.1007/s13311-013-0243-0 Document Type: Article |
Times cited : (25)
|
References (11)
|